Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP)

Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP)

Abstract The Coronavirus Disease 2019 (COVID-19) pandemic curtailed clinical trial activity. Decentralized clinical trials (DCTs) can expand trial access and reduce exposure risk but their feasibility remains uncertain. We evaluated DCT feasibility for atrial fibrillation (AF) patients on oral antic...

Full description

Bibliographic Details
Main Authors: Ashish Sarraju, Clark Seninger, Vijaya Parameswaran, Christina Petlura, Tamara Bazouzi, Kiranbir Josan, Upinder Grewal, Thomas Viethen, Hardi Mundl, Joachim Luithle, Leonard Basobas, Alexis Touros, Michael J. T. Senior, Koen De Lombaert, Kenneth W. Mahaffey, Mintu P. Turakhia, Rajesh Dash
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:npj Digital Medicine
Online Access:https://doi.org/10.1038/s41746-022-00622-9

Internet

https://doi.org/10.1038/s41746-022-00622-9

Similar Items